
Viceroy alleges Vedanta Semiconductor is a ₹2,500-cr sham; co says baseless
In a statement, Vedanta spokesperson said the group "strongly rejects the baseless allegations made in the report regarding Vedanta Semiconductors Pvt Ltd (VSPL)".
"All business activities of VSPL have been transparently disclosed and are in line with statutory norms," it said.
Viceroy said, "VSPL is a sham commodities trading operation designed to improperly avoid classification as a Non-Banking Financial Company (NBFC)".
"This scheme was devised to facilitate
Vedanta Ltd
's remittance of brand fees to Vedanta Resources' (VRL) in April 2025, when it faced a severe liquidity crisis," Viceroy said.
"VSPL's operational illusion needs 24 months of regulatory silence to fulfil its purpose, repaying its offshore lenders and hiding the near-catastrophe of April 2024. While credit analysts are snoozing through the alarm bells, India's regulators are famously light sleepers."
In April 2024, Vedanta Limited (VEDL) faced a severe liquidity crisis. "In response, VEDL reactivated VSPL, not as a semiconductor venture, but as a zero-margin trading entity, whose operations appear to consist entirely of paper-based commodity trading."
"VSPL tapped offshore lenders for a short-term, INR-denominated, 10 per cent NCDs secured by VEDL's stake in HZL (equivalent to 1 per cent of outstanding shares). VSPL then began trading commodities (copper, silver, gold) on a zero-margin basis reminiscent of wash trading," Viceroy alleged.
VSPL, it said, remitted the loan to VEDL as a 24-month 12 per cent loan, with the spread intended to cover the sham operation's costs.
The semiconductor unit, superficially an operating entity, would face reduced scrutiny for loan repayments under FEMA, Companies Act, PMLA and AML frameworks.
"VSPL will likely have to continue these sham operations until FY27, when the loans fall due and repayment will have to be routed back through it. If, at any point, the regulators intervene at VSPL, the lender group is likely facing a total wipeout," the US short-seller alleged.
Vedanta spokesperson in the statement said, "Loans between VSPL and Vedanta Ltd were executed in full compliance with applicable laws, corporate governance standards, and both Vedanta Ltd and VSPL have consistently reported accurate loan terms, interest rates, and collateral in line with statutory norms," it said, adding that it would encourage stakeholders to only reply on verified disclosures and audited financials.
Viceroy, on July 9, said it has taken a short position against the debt of Vedanta Resources, the UK-based parent of Indian miner Vedanta Ltd, and alleged in the report that the British firm is "systematically draining" its Indian unit.
Vedanta had dismissed the report as "a malicious combination of selective misinformation and baseless allegations", and that Research issued it without contacting the group.
Viceroy, in its latest report, said despite Vedanta's claim that it failed to engage, it is yet to receive a response to the issues flagged since July 9.
"For a company so quick to dismiss our findings, one might expect answers to be equally swift. It's been over a week since we formally requested clarification," the short seller added.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)

Business Standard
23 minutes ago
- Business Standard
Brigade Group acquires 20.19 acre land in Bengaluru for ₹588 crore
Bengaluru-based real estate major Brigade Group has acquired a prime ~20.19-acre land parcel in the fast-emerging Whitefield–Hoskote corridor of Bengaluru. The outright purchase was completed at a transaction value of ₹588.33 crore through Ananthay Properties Private Limited, a subsidiary of Brigade Enterprises Limited. Strategically positioned near major IT hubs, industrial corridors, and emerging infrastructure projects, the site will be used for a mixed-use development with an estimated Gross Development Value (GDV) of ₹5,200 crore. 'This acquisition aligns with our vision to develop landmark destinations that integrate living, working, and leisure. The Whitefield–Hoskote belt is poised for exponential growth, and we're excited to contribute meaningfully to its transformation,' said Pavitra Shankar, Managing Director, Brigade Enterprises Limited. The company further noted that with a development potential of approximately 4.2 million square feet, the project in East Bengaluru will integrate residential, commercial, and retail components to shape a vibrant urban ecosystem. This acquisition further reinforces Brigade Group's strong presence in Bengaluru and highlights its commitment to developing integrated urban ecosystems. In May, Brigade Group acquired a ~11-acre land parcel near ITPL in Whitefield, Bengaluru. The site is planned for development into a premium commercial project, with an estimated gross leasable area of approximately 1.5 million square feet and a Gross Development Value (GDV) exceeding ₹2,000 crore, the company stated in its exchange filing. Founded in 1986, Brigade Group operates across Bengaluru, Chennai, Hyderabad, Mysuru, Kochi, Thiruvananthapuram, and GIFT City Ahmedabad, with developments across residential, office, retail, hospitality, and education sectors.
&w=3840&q=100)

Business Standard
23 minutes ago
- Business Standard
Cipla buys 20% stake in iCaltech to broaden respiratory device portfolio
Cipla on Monday announced that it has entered into definitive agreements to acquire a 20 per cent stake in Bengaluru-based iCaltech Innovations, through an investment of approximately ₹5 crore in optionally convertible preference shares and one equity share. The transaction is expected to be completed within a month, subject to customary closing conditions. The investment aligns with Cipla's strategy to strengthen its presence in the respiratory care space, particularly in the diagnostics segment. iCaltech, an ISO 13485 certified medical device company, is engaged in the design, development, manufacturing, and commercialisation of diagnostic products, with a core focus on respiratory applications. Achin Gupta, Global COO, Cipla, said, 'Our decision to invest in iCaltech reflects Cipla's commitment to advancing respiratory diagnostics. As lung leaders with the aim to reduce the existing gap in the current ecosystem, our strategic funding will enable iCaltech to further expand and develop innovative devices.' Cipla said the deal would enable it to partner with iCaltech in developing integrated healthcare solutions by leveraging synergies between pharmaceuticals and medical device technologies. Under the terms, iCaltech will continue to operate independently, while Cipla will hold 20 per cent voting rights post-investment. iCaltech recorded a revenue of ₹6.7 crore in FY25, up from ₹4.19 crore in FY24 and ₹1.28 crore in FY23. The acquisition is part of Cipla's broader focus on expanding its devices, diagnostics, and digital offerings, especially in its core respiratory portfolio.


Time of India
an hour ago
- Time of India
IIT Madras-incubated Plenome bags Rs 6.5crore funding
Plenome founders Anirudh Varna, Prabhu Rajagopal and Vijayaraja Rathinasamy and others. CHENNAI: IIT Madras-incubated Plenome Technologies, a blockchain-based data management startup, has raised a seed funding of Rs 6.5 crore from Ovington Capital Partners, a Luxembourg-based investment firm, UAE-based AADI, and veteran investor Manish Gandhi. Founded by IIT Madras faculty and serial entrepreneur Prabhu Rajagopal, along with Vijayaraja Rathinasamy and Anirudh Varna, it develops blockchain-based applications to protect users' privacy and security of records. Speaking to TOI, Rajagopal said the startup would initially focus on healthcare data, targeting customers in the US, the UK and the UAE market, where the regulatory environment is mature. 'Enterprises have started to increasingly focus on data security and cybersecurity after major security breaches. With the adoption of AI, there are more risks such as data poisoning, where AI models are deliberately fed with misinformation,' he said. Plenome plans to work with hospitals and clinics directly as well as with healthcare software platforms. It is developing an AI-SaaS platform for structured record creation and insight generation. The startup is conducting trial runs for an AI-based electronic data capture, record maintenance and insight generation platforms in the dental specialisation within healthcare, Rajagopal said. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like This Could Be the Best Time to Trade Gold in 5 Years IC Markets Learn More Undo Emerging from the research group on automation and data engineering at IIT-M, Plenome develops blockchain-based solutions for applications in safety-critical fields. It is based on a patented architecture. Plenome is also developing a distributed artificial intelligence (AI) protocol, where multiple agents work together to solve a problem. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now